Published in Biochem Biophys Res Commun on April 02, 1999
Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev (2001) 3.67
Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol Cell Biol (2000) 3.51
Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev (1999) 3.11
The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev (1999) 2.78
A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination. Proc Natl Acad Sci U S A (2000) 2.69
Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J Virol (2002) 2.31
Covalent modifier NEDD8 is essential for SCF ubiquitin-ligase in fission yeast. EMBO J (2000) 2.27
AXR1-ECR1-dependent conjugation of RUB1 to the Arabidopsis Cullin AtCUL1 is required for auxin response. Plant Cell (2002) 2.09
The CUL1 C-terminal sequence and ROC1 are required for efficient nuclear accumulation, NEDD8 modification, and ubiquitin ligase activity of CUL1. Mol Cell Biol (2000) 2.09
Components of an SCF ubiquitin ligase localize to the centrosome and regulate the centrosome duplication cycle. Genes Dev (1999) 2.07
The Arabidopsis cullin AtCUL1 is modified by the ubiquitin-related protein RUB1. Proc Natl Acad Sci U S A (1999) 2.07
The APC11 RING-H2 finger mediates E2-dependent ubiquitination. Mol Biol Cell (2000) 1.89
Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxid Redox Signal (2010) 1.85
The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy. Genes Cancer (2010) 1.80
An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells. EMBO Rep (2002) 1.71
Role of the Arabidopsis RING-H2 protein RBX1 in RUB modification and SCF function. Plant Cell (2002) 1.66
The Cullin3 ubiquitin ligase functions as a Nedd8-bound heterodimer. Mol Biol Cell (2006) 1.22
NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am J Pathol (2006) 1.14
UBXN7 docks on neddylated cullin complexes using its UIM motif and causes HIF1α accumulation. BMC Biol (2012) 1.10
Saccharomyces cerevisiae ubiquitin-like protein Rub1 conjugates to cullin proteins Rtt101 and Cul3 in vivo. Biochem J (2004) 1.07
Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy. Mol Oncol (2012) 1.05
COPing with hypoxia. Semin Cell Dev Biol (2005) 0.96
NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation. Br J Cancer (2010) 0.86
Rub1p processing by Yuh1p is required for wild-type levels of Rub1p conjugation to Cdc53p. Eukaryot Cell (2002) 0.86
Stabilization of HIF through inhibition of Cullin-2 neddylation is protective in mucosal inflammatory responses. FASEB J (2014) 0.83
DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase. Mol Cell Biol (2013) 0.82
AXR1-ECR1 and AXL1-ECR1 heterodimeric RUB-activating enzymes diverge in function in Arabidopsis thaliana. Plant Mol Biol (2011) 0.81
Phosphorylation of VACM-1/Cul5 by protein kinase A regulates its neddylation and antiproliferative effect. J Biol Chem (2009) 0.80
Inactivating UBE2M impacts the DNA damage response and genome integrity involving multiple cullin ligases. PLoS One (2014) 0.80
Identification and characterization of three novel cold acclimation-responsive genes from the extremophile hair grass Deschampsia antarctica Desv. Extremophiles (2003) 0.78
Inhibition of NEDD8 and FAT10 ligase activities through the degrading enzyme NEDD8 ultimate buster 1: A potential anticancer approach. Oncol Lett (2016) 0.75
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83
Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation (2000) 4.81
Ubiquitin-like proteins: new wines in new bottles. Gene (2000) 3.46
p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest (2001) 3.02
Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem (1997) 2.64
Identification of three major sentrinization sites in PML. J Biol Chem (1998) 2.54
Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol (1996) 2.47
Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem (2000) 2.34
Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem (1998) 2.15
Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway. J Biol Chem (1999) 2.15
Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation (2000) 2.15
Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation (2001) 2.03
A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation (1999) 1.93
Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J Biol Chem (1997) 1.86
Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J Biol Chem (1997) 1.80
Structural characterization of the TAP molecule: a phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1. Cell (1986) 1.77
Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res (2000) 1.53
TAP, a novel T cell-activating protein involved in the stimulation of MHC-restricted T lymphocytes. J Exp Med (1986) 1.49
Identification of defects in glycosylphosphatidylinositol anchor biosynthesis in the Thy-1 expression mutants. J Biol Chem (1991) 1.41
Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol (1991) 1.39
Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex. FEBS Lett (1999) 1.33
Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen. J Biol Chem (2000) 1.33
Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins. J Biol Chem (2000) 1.30
Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem (2001) 1.29
Characterization of a second member of the sentrin family of ubiquitin-like proteins. J Biol Chem (1998) 1.28
Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation (1998) 1.25
A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8 conjugation in vivo. J Biol Chem (2000) 1.24
Correction of the class H defect in glycosylphosphatidylinositol anchor biosynthesis in Ltk- cells by a human cDNA clone. J Biol Chem (1993) 1.20
Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest (1997) 1.20
C-reactive protein: linking inflammation to cardiovascular complications. Circulation (2001) 1.18
NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J Biol Chem (2001) 1.17
Cleavage of the C-terminus of NEDD8 by UCH-L3. Biochem Biophys Res Commun (1998) 1.16
Stimulation of T cells via the TAP molecule, a member in a family of activating proteins encoded in the Ly-6 locus. J Immunol (1987) 1.14
Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Neuropathol Appl Neurobiol (2005) 1.13
Identification of a missing link in glycosylphosphatidylinositol anchor biosynthesis in mammalian cells. J Biol Chem (1992) 1.13
Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene (1998) 1.12
Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. Am J Respir Crit Care Med (1999) 1.10
Complexity of ethanolamine phosphate addition in the biosynthesis of glycosylphosphatidylinositol anchors in mammalian cells. J Biol Chem (1992) 1.04
The expression, function, and ontogeny of a novel T cell-activating protein, TAP, in the thymus. J Immunol (1986) 1.03
Activation-induced aggregation and processing of the human Fas antigen. Detection with cytoplasmic domain-specific antibodies. J Biol Chem (1997) 1.03
The von Hippel-Lindau tumor suppressor gene product promotes, but is not essential for, NEDD8 conjugation to cullin-2. J Biol Chem (1999) 1.01
Gene encoding T-cell-activating protein TAP maps to the Ly-6 locus. Proc Natl Acad Sci U S A (1986) 1.01
Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene (1998) 0.99
Biosynthesis of phosphatidylinositol-glycan (PI-G)-anchored membrane proteins in cell-free systems: PI-G is an obligatory cosubstrate for COOH-terminal processing of nascent proteins. Proc Natl Acad Sci U S A (1992) 0.96
Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription. Lipids (1996) 0.93
Presence of connectin-like protein in white blood cells and platelets. Tohoku J Exp Med (1984) 0.92
Analysis of thymocyte MHC specificity with thymocyte hybridomas. J Exp Med (1984) 0.90
Inhibition of glycosylphosphatidylinositol anchor formation by mannosamine. J Biol Chem (1992) 0.89
Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine. Eur J Pharmacol (1984) 0.88
Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step. Blood (1994) 0.87
Life and death in the cardiovascular system. Circulation (1997) 0.87
A comparative study on the xenotransplantability of human solid tumors into mice with different genetic immune deficiencies. Int J Cancer (1991) 0.87
Identification of novel isoforms of human RAD52. Biochim Biophys Acta (1999) 0.86
NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation. Br J Cancer (2010) 0.86
A cyclic hexapeptide is a potent antagonist of alpha 4 integrins. J Immunol (1997) 0.86
Local specificity in responses of canine coronary vessels to oxygen deficiency and antianginal drugs. Arch Int Pharmacodyn Ther (1977) 0.85
Effectiveness of washed platelet concentrate and red cell transfusions for a patient with anhaptoglobinemia with antihaptoglobin antibody. Transfus Med (2002) 0.85
Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice. J Immunol (1987) 0.84
Measurement of time-dependent CP-violating asymmetries in B0-->phiK(0)S, K+K-K0(S), and eta'K0(S) decays. Phys Rev Lett (2003) 0.83
A tissue plasminogen activator/P-selectin fusion protein is an effective thrombolytic agent. Circulation (1997) 0.83
Do P1 and N1 evoked by the ERP task reflect primary visual processing in Parkinson's disease? Doc Ophthalmol (2001) 0.82
GNB1L, a gene deleted in the critical region for DiGeorge syndrome on 22q11, encodes a G-protein beta-subunit-like polypeptide. Biochim Biophys Acta (2000) 0.82
Apparent diffusion coefficient calculated with relatively high b-values correlates with local failure of head and neck squamous cell carcinoma treated with radiotherapy. AJNR Am J Neuroradiol (2011) 0.82
Visual event-related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration, and Parkinson's disease. J Neurol (2000) 0.81
Effect of neo red cells on hemodynamics and blood gas transport in canine hemorrhagic shock and its safety for vital organs. Artif Cells Blood Substit Immobil Biotechnol (1994) 0.81
Expression of T-cell-activating protein in peripheral lymphocyte subsets. Proc Natl Acad Sci U S A (1986) 0.81
Observation of the D(sJ)(2317) and D(sJ)(2457) in B decays. Phys Rev Lett (2003) 0.81
Effect of interstimulus interval on visual P300 in Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 0.79
Serum IL-18 levels in patients with various hematological disorders. Haematologia (Budap) (2000) 0.79
The correlation between P300 alterations and regional cerebral blood flow in non-demented Parkinson's disease. Neurosci Lett (2000) 0.79
Differential expression of glycosylphosphatidylinositol-anchored proteins in a murine T cell hybridoma mutant producing limiting amounts of the glycolipid core. Implications for paroxysmal nocturnal hemoglobinuria. J Clin Invest (1992) 0.79
Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor. Am J Physiol Heart Circ Physiol (2000) 0.79
Effect of leukotrienes, 12-HETE, histamine, bradykinin, and 5-hydroxytryptamine on in vivo rabbit cerebral arteriolar diameter. J Cereb Blood Flow Metab (1985) 0.79
Evidence for a possible role of the brain kallikrein-kinin system in the modulation of the cerebral circulation. Circ Res (1985) 0.79
General pharmacology of ceftizoxime sodium. Arzneimittelforschung (1980) 0.78
Biosynthesis and processing of the glycosylphosphatidylinositol anchor in mammalian cells. Semin Immunol (1994) 0.78
Detectability of simulated interstitial pneumonia on chest radiographs: comparison between irradiation side sampling indirect flat-panel detector and computed radiography. Br J Radiol (2014) 0.78
Selection of thymocyte MHC restriction specificity in vitro. J Mol Cell Immunol (1984) 0.77
Dynamic contrast-enhanced MRI of oral squamous cell carcinoma: a preliminary study of the correlations between quantitative parameters and the clinical stage. Br J Radiol (2015) 0.77
Inhibitory effect of Cu2+ on nitroglycerin-induced vasodilation. Eur J Pharmacol (1984) 0.77
The inhibitory effect of TMK688, a novel anti-allergic drug having both 5-lipoxygenase inhibitory activity and anti-histamine activity, against bronchoconstriction, leukotriene production and inflammatory cell infiltration in sensitized guinea pigs. Clin Exp Allergy (1997) 0.77
Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies. Acta Haematol (2000) 0.77
Human IL-18 bioactivity in hematological malignancies with highly elevated serum IL-18 levels. Acta Haematol (2000) 0.77
A new fluorescent assay for sialyltransferase. Carbohydr Res (2001) 0.77
The value of serum soluble transferrin receptor (sTfR) determination in hematological malignancies. Haematologia (Budap) (1998) 0.77